Mark Ahn’s 20-year career has included many biopharmaceutical companies and academia. He earned his Ph.D. from the University of South Australia, and he is a Principal at Pukana Partners. He is an adjunct at Portland State University and Carnegie Mellon University. He is the President and Chief Executive Officer and Director of Galena Biopharma. Dr. Ahn was the Chief Executive Officer of Hana Biosciences, and he also serves on the public and venture capital-backed Board of Directors and Scientific Advisory Board. His leadership roles combined are what equates to his success.
2. He’s Published Countless Articles
Mark Ahn has not only served in a number of leadership roles, but he has also the author of over 50 different peer-reviewed journal articles and books. One of his most popular publications is “Building the Case for Biotechnology.” Some of the other noteworthy publications include “Competency-Based Benchmarking: Revolutionizing Biopharmaceutical Product;” “Negotiating, Power, and Strategic Competition: A Teaching Case;” “Technological Invention to Product Innovation: A Project Management Approach;” and “From Leaders to Leadership: Managing Change.” These are just a few of the articles he’s published during his career, and there are countless others.
3. He Has Excellent Credentials
Dr. Ahn received a B.A. and M.B.A. from Chaminade University. He also earned an M.A. from Victoria University before getting a Ph.D. from the University of South Australia. Before the Ph.D., he was a graduate fellow in Economics at Essex University and a Henry Crown Fellow at the Aspen Institute class of 2001. Today he is also an adjunct professor at Carnegie Mellon and Portland State University.
Mark Ahn is a Great Leader of His Time
Mark Ahn is one of the great leaders in the biotechnology industry. He developed a Center for the Civic and Community Engagement at the College of New Jersey (TCNJ). Ahn develops future leaders and will integrate non-profit research and teaching into their course curriculum.